Search research articles
Contact Us
Filters
Showing results (11-20 of 111) with videos related to
Page
of 12
Sort By:
Archives of Dermatological Research
|
January 1, 1982
Intraindividual variations of 8-methoxypsoralen plasma levels
M Schäfer-Korting, H C Korting
Archives of Dermatology
|
February 1, 1992
Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin
H C Korting, M Schäfer-Korting
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 4, 2001
An improved high-performance liquid chromatographic method for the determination of sphingosine-1-phosphate in complex biological materials
L Ruwisch, M Schäfer-Korting, B Kleuser
Der Internist
|
October 1, 1981
[Pharmacokinetic and biological effective time of beta-receptor blockers in renal insufficiency]
H Knauf, M Schäfer-Korting, E Mutschler
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
February 1, 1987
Influence of phosphodiesterase inhibition and of carbachol on inotropic effects of 8-substituted cyclic AMP analogues
M Korth, J Engels, M Schäfer-Korting
Skin Pharmacology and Physiology
|
September 12, 2012
Morphine metabolism in human skin microsomes
S Heilmann, S Küchler, M Schäfer-Korting
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 1, 2000
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties
V Jenning, M Schäfer-Korting, S Gohla
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
December 1, 1981
Involvement of cyclic AMP in the direct inotropic action of amrinone. Biochemical and functional evidence
P Honerjäger, M Schäfer-Korting, M Reiter
International Journal of Pharmaceutics
|
March 4, 2000
Solid lipid nanoparticles as drug carriers for topical glucocorticoids
C S Maia, W Mehnert, M Schäfer-Korting
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 24, 2007
Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio
C Schackert, H C Korting, M Schäfer-Korting
Page
of 12
Search research articles
Search
Showing results (11-20 of 111) with videos related to
Sort By:
Page
of 12
Archives of Dermatological Research
|
January 1, 1982
Intraindividual variations of 8-methoxypsoralen plasma levels
M Schäfer-Korting, H C Korting
Archives of Dermatology
|
February 1, 1992
Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin
H C Korting, M Schäfer-Korting
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 4, 2001
An improved high-performance liquid chromatographic method for the determination of sphingosine-1-phosphate in complex biological materials
L Ruwisch, M Schäfer-Korting, B Kleuser
Der Internist
|
October 1, 1981
[Pharmacokinetic and biological effective time of beta-receptor blockers in renal insufficiency]
H Knauf, M Schäfer-Korting, E Mutschler
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
February 1, 1987
Influence of phosphodiesterase inhibition and of carbachol on inotropic effects of 8-substituted cyclic AMP analogues
M Korth, J Engels, M Schäfer-Korting
Skin Pharmacology and Physiology
|
September 12, 2012
Morphine metabolism in human skin microsomes
S Heilmann, S Küchler, M Schäfer-Korting
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 1, 2000
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties
V Jenning, M Schäfer-Korting, S Gohla
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
December 1, 1981
Involvement of cyclic AMP in the direct inotropic action of amrinone. Biochemical and functional evidence
P Honerjäger, M Schäfer-Korting, M Reiter
International Journal of Pharmaceutics
|
March 4, 2000
Solid lipid nanoparticles as drug carriers for topical glucocorticoids
C S Maia, W Mehnert, M Schäfer-Korting
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 24, 2007
Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio
C Schackert, H C Korting, M Schäfer-Korting
Page
of 12